93978-5 |
Complement C4.functional |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Complement C4.functional [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
HEM/BC |
|
93978-5 |
|
|
|
|
Both |
|
|
|
0 |
C4.functional SerPl-aCnc |
|
|
|
|
|
Arbitrary concentration; Beta 1 E-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.68 |
2.67 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
93979-3 |
Chikungunya virus Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Chikungunya virus IgG Ab [Presence] in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
93979-3 |
|
|
|
|
Both |
|
|
|
0 |
CHIKV IgG SerPl Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHIKV; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.72 |
2.67 |
|
|
|
|
|
|
|
|
|
|
Release 2.72: SYSTEM: Updated to Ser/Plas for consistency of usage.; |
0 |
9398-9 |
Reticulin Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Reticulin Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
9398-9 |
|
|
|
|
Both |
|
|
|
0 |
Reticulin Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Gastro; Gastroenterology; GI; Point in time; Random; Reticuline; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; UniversalLabOrders |
2.75 |
1.0i |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
93980-1 |
Iothalamate |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Iothalamate [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
CHEM |
|
93980-1 |
|
|
|
|
Both |
|
|
|
0 |
Iothalamate SerPl-mCnc |
|
|
|
|
|
Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
93981-9 |
Hydrogen/Expired gas^2H post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93981-9 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 2h p carb |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; 2h p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93982-7 |
Hydrogen/Expired gas^1.5H post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93982-7 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 1.5h p carb |
|
|
|
|
|
1 1/2 hours; 1 1/2 HR; 1.5h p carb; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93983-5 |
Hydrogen/Expired gas^1H post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93983-5 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 1h p carb |
|
|
|
|
|
1 hour; 1.0Hr; 1h p carb; 60 min; 60 minutes; 60M; 60min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93984-3 |
Hydrogen/Expired gas^45M post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93984-3 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 45M p carb |
|
|
|
|
|
45M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93985-0 |
Hydrogen/Expired gas^30M post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93985-0 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 30M p carb |
|
|
|
|
|
30M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93986-8 |
Hydrogen/Expired gas^15M post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93986-8 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 15M p carb |
|
|
|
|
|
15M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93987-6 |
Hydrogen/Expired gas^pre dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93987-6 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 pre carb |
|
|
|
|
|
Before; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Percent; Point in time; pre carb; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93988-4 |
Hydrogen/Expired gas^post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93988-4 |
|
|
|
|
Observation |
|
|
|
0 |
Breath H2 p carb |
|
|
|
|
|
After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93989-2 |
Carbohydrate challenge panel |
- |
Exhl gas |
Pt |
- |
|
|
ACTIVE |
Carbohydrate challenge panel - Exhaled gas |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
93989-2 |
|
|
|
|
Order |
|
|
|
0 |
Carb chal Pnl ExG |
|
|
|
|
|
Breath; Carb chal Pnl; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random |
2.67 |
2.67 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
9399-7 |
Ribonucleoprotein extractable nuclear Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Ribonucleoprotein extractable nuclear Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
9399-7 |
|
|
|
|
Both |
|
|
|
0 |
ENA RNP Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ENA; ENA RNP; NA; Nuc; Point in time; Random; Ribonuclear protein; RNP; Ro; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0i |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
93990-0 |
Osmolality^post 1H FFst |
Osmol |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Serum or Plasma--1 hour post fluid fast |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
93990-0 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality p 1h FFST SerPl |
|
|
|
|
|
1 hour; 1.0Hr; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 1h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
93991-8 |
Osmolality^post 2H FFst |
Osmol |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Serum or Plasma--2 hours post fluid fast |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
93991-8 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality p 2h FFST SerPl |
|
|
|
|
|
120 min; 120 minutes; 120min; 2 hours; After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 2h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
93992-6 |
Osmolality^post 3H FFst |
Osmol |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Serum or Plasma--3 hours post fluid fast |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
93992-6 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality p 3h FFST SerPl |
|
|
|
|
|
After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 3h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
93993-4 |
Osmolality^post 4H FFst |
Osmol |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Serum or Plasma--4 hours post fluid fast |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
93993-4 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality p 4h FFST SerPl |
|
|
|
|
|
After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 4h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
93994-2 |
Osmolality^post 5H FFst |
Osmol |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Serum or Plasma--5 hours post fluid fast |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
93994-2 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality p 5h FFST SerPl |
|
|
|
|
|
After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 5h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
93995-9 |
Osmolality^post 6H FFst |
Osmol |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Serum or Plasma--6 hours post fluid fast |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
93995-9 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality p 6h FFST SerPl |
|
|
|
|
|
After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 6h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
93996-7 |
Osmolality^post 7H FFst |
Osmol |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Osmolality of Serum or Plasma--7 hours post fluid fast |
|
ADD |
DefinitionDescription |
|
|
mOsm/kg |
|
|
|
|
|
|
CHAL |
|
93996-7 |
|
|
|
|
Observation |
|
|
|
0 |
Osmolality p 7h FFST SerPl |
|
|
|
|
|
After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 7h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
mosm/kg |
|
|
|
0 |
93997-5 |
Sodium^1H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Sodium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
93997-5 |
|
|
|
|
Observation |
|
|
|
0 |
Sodium 1h p Vaso SerPl-sCnc |
|
|
|
|
|
1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; Na; Na+; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
93998-3 |
Potassium^1H post dose vasopressin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Potassium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
93998-3 |
|
|
|
|
Observation |
|
|
|
0 |
Potassium 1h p Vaso SerPl-sCnc |
|
|
|
|
|
1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; k; K+; Level; p dose; Pl; Plasma; Plsm; Point in time; Potass; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
93999-1 |
Creatinine^1H post dose vasopressin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Creatinine [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin |
|
ADD |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
93999-1 |
|
|
|
|
Observation |
|
|
|
0 |
Creat 1h p Vaso SerPl-mCnc |
|
|
|
|
|
1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VP |
2.67 |
2.67 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
94-3 |
Cefodizime |
Titr |
Isolate+Ser |
Pt |
SemiQn |
SBT |
|
ACTIVE |
Cefodizime [Susceptibility] by Serum bactericidal titer |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
ABXBACT |
|
94-3 |
|
SBT |
|
|
Observation |
|
|
|
0 |
Cefodizime Titr SBT |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Timecef; Titer; Titered; Titre; Ttr |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |